Publications by authors named "Valerio Alonzi"

Claim this Profile
R
Real-Life Efficacy of Single-Inhaler Triple Therapy with Budesonide/Glycopyrronium/Formoterol Fumarate in Persistent COPD Users: A Retrospective Database Study.
Bruno Sposato, Leonardo Gianluca Lacerenza, Sara Croce, Elisa Petrucci, Valentina Fabbrini, Valerio Alonzi

Biomedicines· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral and alveolar biomarkers of fibrotic hypersensitivity pneumonitis.
Miriana D'Alessandro, Laura Bergantini, Paolo Cameli, Claudia Landi, Nicola Lanzarone, Valerio Alonzi

Panminerva Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis, Familial Pulmonary Fibrosis and Progressive Fibrosing Interstitial Lung Diseases: A Real-World Study.
Paolo Cameli, Valerio Alonzi, Miriana d'Alessandro, Laura Bergantini, Elena Pordon

Biomedicines· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunologic responses to antifibrotic treatment in IPF patients.
Miriana d'Alessandro, Laura Bergantini, Paolo Cameli, Matteo Fanetti, Lorenzo Alderighi, Valerio Alonzi

Int Immunopharmacol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bronchoalveolar lavage and serum KL-6 concentrations in chronic hypersensitivity pneumonitis: correlations with radiological and immunological features.
Nicola Lanzarone, Francesco Gentili, Valerio Alonzi, Laura Bergantini, Miriana d'Alessandro

Intern Emerg Med· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum KL-6 concentrations as a novel biomarker of severe COVID-19.
Miriana d'Alessandro, Paolo Cameli, Rosa Metella Refini, Laura Bergantini, Valerio Alonzi

J Med Virol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Follow-Up of Patients With Idiopathic Pulmonary Fibrosis Treated With Pirfenidone or Nintedanib: A Real-Life Comparison Study.
Paolo Cameli, Rosa Metella Refini, Laura Bergantini, Miriana d'Alessandro, Valerio Alonzi

Front Mol Biosci· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Krebs von den Lungen-6 as a biomarker for disease severity assessment in interstitial lung disease: a comprehensive review.
Miriana d'Alessandro, Laura Bergantini, Paolo Cameli, Lucia Vietri, Nicola Lanzarone, Valerio Alonzi

Biomark Med· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum KL-6 levels in pulmonary Langerhans' cell histiocytosis.
Miriana d'Alessandro, Laura Bergantini, Paolo Cameli, Nicola Lanzarone, Maria Antonietta Mazzei, Valerio Alonzi

Eur J Clin Invest· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis